CSTONE PHARMACEUTICALS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9 HKD | 0.00% |
|
+5.88% | -60.35% |
| 04-24 | Cstone Pharmaceuticals Logs Lower Loss for 2023, Shares Up By Nearly 5% | MT |
| 04-23 | CStone Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 845M 117M 912M 9.33B | Sales 2025 * | 978M 135M 1.06B 10.81B | Capitalization | 1.06B 146M 1.15B 11.73B |
|---|---|---|---|---|---|
| Net income 2024 * | -454M -62.66M -490M -5.02B | Net income 2025 * | -159M -21.94M -172M -1.76B | EV / Sales 2024 * | 0.52 x |
| Net cash position 2024 * | 621M 85.77M 671M 6.87B | Net cash position 2025 * | 463M 63.91M 500M 5.12B | EV / Sales 2025 * | 0.61 x |
| P/E ratio 2024 * |
-2.16
x | P/E ratio 2025 * |
-6.17
x | Employees | 474 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.28% |
More Fundamentals
* Assessed data
More news
Latest transcript on CStone Pharmaceuticals
More recommendations
More press releases
| 1 week | +5.88% | ||
| Current month | -4.26% | ||
| 1 month | -6.25% | ||
| 3 months | -49.44% | ||
| 6 months | -54.31% | ||
| Current year | -60.35% |
1 week
0.83
0.93
1 month
0.800.98
Current year
0.802.38
1 year
0.803.33
3 years
0.8019.12
5 years
0.8019.12
10 years
0.8019.12
| Managers | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 60 | 30/11/16 |
Jun Cheng
DFI | Director of Finance/CFO | 44 | 28/02/22 |
Ying Hua Zhang
COO | Chief Operating Officer | 44 | 31/07/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Edward Hu
BRD | Director/Board Member | 61 | 08/07/21 |
Wei Li
BRD | Director/Board Member | 52 | 30/09/18 |
Ting Yuk Wu
BRD | Director/Board Member | 69 | 13/02/19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.75% | 4 M€ | -27.92% | ||
| 0.01% | 117 M€ | +1.11% | - | |
| 0.00% | 4 M€ | -4.41% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.9 | 0.00% | 1,700,000 |
| 25/04/24 | 0.9 | -2.17% | 624,000 |
| 24/04/24 | 0.92 | +6.98% | 1,388,000 |
| 23/04/24 | 0.86 | +3.61% | 650,260 |
| 22/04/24 | 0.83 | -2.35% | 453,500 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in domestic market.
Calendar
21/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.8331
CNY
Average target price
3.186
CNY
Spread / Average Target
+282.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -60.35% | 146M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- 2616 Stock
